Anavex Life Sciences Corp (AVXL)

[B60611]

AVATAR is even worse. Missling stated it was 50% enrolled 17 months ago, which means they’ve averaged enrolling 1 or slightly fewer participants per month since then. This absurd delay has been an absolute boon for Missling as he’ll pocket an extra 1-1.5 million (Jan 2021, Aug 2021, Jan 2022 most likely) in options awards with routine vesting requirements for unrelated trials. Meanwhile, he was able to easily suppress the share price / his strike price, while longs fell prey to the misdirection and blamed the “cabal.” Dude is batting .000 on his initial timeline guidance and only slightly better on his first revised guidance. You cannot tell me it is unintentional.